Clinical Trials Logo

Pectus Excavatum clinical trials

View clinical trials related to Pectus Excavatum.

Filter by:

NCT ID: NCT03926078 Recruiting - Pectus Excavatum Clinical Trials

Three-dimensional Optical Surface Imaging as a Diagnostic Tool in Pectus Excavatum

3D PECTUS
Start date: August 21, 2019
Phase: N/A
Study type: Interventional

Pectus excavatum (PE) is the most common anterior chest wall deformity. Currently, a chest radiography (CR) or Computed Tomography (CT) scan is acquired to determine and objectify pectus severity using the Haller Index. Alongside other determinants, the Haller Index value is used in the proces of clinical decision making and determine surgical candidacy. However, cross-sectional imaging based calculation of the Haller Index implies exposure to ionizing radiation that should be limited at all times to diminish the cumulative long-term risks of malignancy. Especially in pectus patients that often concerns children. Three-dimensional (3D) optical surface imaging offers a non-invasive, radiation-free alternative that may be used to obtain thoracic measures and determine pectus severity. However, for 3D images/scans to be used as a diagnostic tool in the proces of clinical decision making and determine surgical candidacy, its diagnostic accuracy should be evaluated. This will be investigated utilizing a pilot study design as no prior accuracy studies are available.

NCT ID: NCT03346876 Recruiting - Surgery Clinical Trials

Autonomic Dysfunction in Patients With Pectus Excavatum.

ADPE
Start date: August 1, 2017
Phase: N/A
Study type: Observational [Patient Registry]

Investigators conducted a pilot study to to evaluate the autonomic function in participants with pectus excavatum before and after Nuss surgery.

NCT ID: NCT02528656 Recruiting - Pectus Excavatum Clinical Trials

Physiological Assessments During Non Operative Treatment on the Chest Wall Deformities

PECTUS
Start date: January 12, 2015
Phase: N/A
Study type: Interventional

The physiological assessment in non-operative treatment on chest wall deformities, are still unclear today. These functional benefits outweigh the aesthetic benefits associated with anatomical improvement. The functional benefits, ventilation, hemodynamic and neurologic, have never been evaluated. Assessment of Effects on parasympathetic activity of the autonomic nervous system, global health criterion measured by noninvasive methods. Anatomic evaluation, between the initial and final assessment by objective measures 1) of the chest wall by MRI, and 2) of the heart by echocardiography. Noninvasive physiological assessment at rest and during exercise in respiratory function exploration flows and volumes, cardiac function by flow measurement, and overall metabolic function test effort (VO2max). Subjective assessment of functional gain between the initial and final balance sheet, based on EVA scales, valued by patients, parents and doctors.

NCT ID: NCT01486953 Recruiting - Pectus Excavatum Clinical Trials

Pulmonary Mechanics During Minimally Invasive Repair of Pectus Excavatum

Start date: November 2011
Phase: Phase 4
Study type: Interventional

The aim of the current study was to compare the effects of sevoflurane and desflurane on respiratory mechanics in patients undergoing repair of pectus excavatum.